Purdue Research Foundation

Novosteo, Inc. is a startup developing and delivering new drugs for the treatment of bone injury and diseases that impact patients' morbidity, mortality and loss of mobility and productivity associated with bone fractures, bone metastasis and infection. Scientific co-founders Stewart Low and Philip Low of Purdue University have created a proprietary chemistry approach to bone targeting and have discovered novel biologics that accelerate bone regeneration by delivering anabolic agents preferentially to fracture surfaces.

ClearBlade is an Edge Computing software company enabling enterprises to rapidly engineer and run secure, real-time, scalable IoT applications. ClearBlade was built for the enterprise from the ground up to run securely in any cloud, on-premise, and at the edge. ClearBlade enables companies to ingest, analyze, adapt and act on any data in real time and at an extreme scale. Users can unleash their data by leveraging local computing, artificial intelligence, and actionable visualizations while integrating with any enterprise system - all from a single platform. The industry-leading ClearBlade Edge delivers the full power of the ClearBlade Platform directly to devices and gateways. The ClearBlade Edge runs autonomously - independent of network connectivity - ensuring resiliency and security. ClearBlade’s patented communications-agnostic AutoSync technology guarantees your environment is always up-to-date. ClearBlade is fully extensible with a suite of proven components and integrations to deliver solutions quickly and at scale. ClearBlade empowers you to focus on business results and outcomes. Providing a consistent platform across edge, cloud, and on-premise environments. ClearBlade is headquartered in Austin, TX.

BioDynamic Imaging delivers better drug assessment in three-dimensional (3D) living tissue samples, revealing a comprehensive phenotypic response that is more physiologically meaningful than from conventional 2D or monolayer screens. Our technique is label-free and probes up to 1 mm deep in living tissue to study drug response in heterogeneous tissue environments. BioDynamic Imaging converts all forms of functional cellular motions into contrast maps of cellular mechanisms of action.

Confluence Pharmaceuticals is developing novel therapeutic medications for neurological development disorders. The company's current focus is advancing a novel drug discovery that improves social and communication impairments for individuals with Autism Spectrum Disorders and Fragile X Syndrome.

Brightlamp is a computational medicine company that produces consumer ready software for medical diagnostics. It focuses on medical mobility by using software based applications on mobile devices to diagnose symptoms. The company is on a mission to make the world medically mobile by reforming the way people interact with technology and their health. Brightlamp was founded in 2015 and is headquartered in West Lafayette, Indiana.

BioDynamic Imaging delivers better drug assessment in three-dimensional (3D) living tissue samples, revealing a comprehensive phenotypic response that is more physiologically meaningful than from conventional 2D or monolayer screens. Our technique is label-free and probes up to 1 mm deep in living tissue to study drug response in heterogeneous tissue environments. BioDynamic Imaging converts all forms of functional cellular motions into contrast maps of cellular mechanisms of action.

SPEAK MODalities, LLC provides evidence backed software solutions for developing language skills in children with autism and delays in speech development. It offers SPEAKall!, a tablet and iPad app differentiated with a special feature set for children with autism spectrum and developmental disorders.

Developer of sensor technology for smartphones. The company's technology improves smartphone battery life and service by monitoring and adjusting the phone's cellular antenna to automatically run efficiently.

BioDynamic Imaging delivers better drug assessment in three-dimensional (3D) living tissue samples, revealing a comprehensive phenotypic response that is more physiologically meaningful than from conventional 2D or monolayer screens. Our technique is label-free and probes up to 1 mm deep in living tissue to study drug response in heterogeneous tissue environments. BioDynamic Imaging converts all forms of functional cellular motions into contrast maps of cellular mechanisms of action.

Microfluidic Innovations LLC engages in the design, development, and production of programmable lab-on-a-chip systems. It offers AssayMark System, a platform that allows users to develop assays without the need for microfluidic chip design and fabrication cycles; and software-programmable lab-on-a-chip, a platform for developing new microfluidic assays that are used in drug discovery, genomics, proteomics, and cell-based research applications for scientists and researchers. The company provides its products for drug discovery, clinical diagnostics, biochemistry, and cell biology applications. Microfluidic Innovations LLC was founded in 2009 and is based in West Lafayette, Indiana.

Perfinity Biosciences offers consumable kits and automated instrument solutions that simplify protein sample preparation. Perfinity Biosciences products enable unprecedented levels of reproducibility and speed in easy-to-use formats. Perfinity's products include beads for proteomics applications and a solution testing device that is compatible with a wide range of workflows like solid tissues, gels, and sample pellets.

Perfinity Biosciences offers consumable kits and automated instrument solutions that simplify protein sample preparation. Perfinity Biosciences products enable unprecedented levels of reproducibility and speed in easy-to-use formats. Perfinity's products include beads for proteomics applications and a solution testing device that is compatible with a wide range of workflows like solid tissues, gels, and sample pellets.